Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

RAGHX vs SCHLX overlap: 52% of top holdings shared

Bottom line

How much do RAGHX and SCHLX overlap?

52% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 57.6% of RAGHX's assets and 46.4% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.

SCHLX holds far more positions (65 vs 24), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

RAGHXSCHLX
Weight overlap (top 25)52%
Shared holdings11
Weight in shared holdings57.6%46.4%
Total positions2465
Expense ratio1.41%1.06%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings RAGHX and SCHLX have in common

Holding% of RAGHX% of SCHLXOverlap
Eli Lilly & Company LLY14.84%13.85%13.85%
Abbvie Inc ABBV5.52%4.90%4.90%
Vertex Pharmaceuticals Inc VRTX5.32%2.45%2.45%
Merck & Company Inc MRK5.06%4.85%4.85%
Unitedhealth Group Inc UNH4.65%5.73%4.65%
Mckesson Corp MCK4.57%2.05%2.05%
Intuitive Surgical Inc ISRG3.89%2.69%2.69%
Amgen Inc AMGN3.85%2.88%2.88%
Thermo Fisher Scientific Inc TMO3.65%3.46%3.46%
Danaher Corp DHR3.37%2.13%2.13%
Regeneron Pharmaceuticals Inc REGN2.90%1.43%1.43%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in RAGHX

  1. West Pharmaceutical Services Inc — 5.92%
  2. Mettler-toledo International Inc — 3.99%
  3. Cooper Companies Inc (the) — 3.81%
  4. Idexx Laboratories Inc — 3.77%
  5. Lumexa Imaging Holdings Inc — 3.60%
  6. Healthequity Inc — 3.47%
  7. Dexcom Inc — 3.05%
  8. Align Technology Inc — 2.88%
  9. Steris Plc — 2.32%
  10. U.s. Physical Therapy Inc — 2.30%
  11. Globus Medical Inc — 2.21%
  12. Medline Inc — 1.88%
  13. Prestige Consumer Healthcare Inc — 1.65%

Only in SCHLX

  1. Johnson & Johnson — 6.19%
  2. AstraZeneca PLC — 3.80%
  3. Novartis AG — 2.90%
  4. Gilead Sciences Inc — 2.78%
  5. Stryker Corp — 2.61%
  6. Abbott Laboratories — 2.39%
  7. Boston Scientific Corp — 2.10%
  8. Novo Nordisk A/S — 1.73%
  9. Medtronic PLC — 1.54%
  10. Bristol-Myers Squibb Co — 1.50%
  11. Cardinal Health Inc — 1.34%
  12. Cencora Inc — 1.26%
  13. Roche Holding AG — 1.24%
  14. Pfizer Inc — 1.17%

Asset mix

Asset typeRAGHXSCHLX
Stocks98.5%99.6%
Cash & short-term funds—0.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryRAGHXSCHLX
US96.2%85.7%
CH—5.2%
GB—3.8%
IE2.3%1.5%
DK—1.7%
FR—1.0%
NL—1.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do RAGHX and SCHLX overlap?
About 52% by weight. 11 securities appear in both funds' top 25 holdings; they make up 57.6% of RAGHX's assets and 46.4% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do RAGHX and SCHLX have in common?
The largest shared holdings are Eli Lilly & Company, Abbvie Inc, Merck & Company Inc, Unitedhealth Group Inc, Thermo Fisher Scientific Inc.
Should I own both RAGHX and SCHLX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, RAGHX or SCHLX?
SCHLX is broader, with 65 positions versus 24 for RAGHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.